Jongkundang has ranked among the top searched stocks for 3 days within the past month.


As of 9:30 AM on the 4th, Jongkundang is trading at 184,000 KRW, down 1.34% from the previous day. This represents a 20.0% decline compared to January 7. Jongkundang is known as a leading pharmaceutical company in the industry, focusing on therapeutics.

Over the past 5 days, individual investors have net purchased 63,604 shares, while foreigners and institutions have net sold 13,398 shares and 48,493 shares, respectively.


On January 26, Jongkundang was a market topic with the announcement "Completion of Phase 2 Clinical Trial for COVID-19 Therapeutic... Second upon Approval."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing